Nice goals; fast track FDA approval, up-list (yeah, every pennies dream), partnership or get acquired. I guess it is just sitting back and waiting some more but maybe 2017 can be a watershed year. I do hope that they become part of the now big gumint push (with lots of money) considering opioid treatments are clearly a part of that bill.
Lots of apparent positives yet here we sit with an ask < .03.
News 
Market Data 
Discover 
